13:36 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma other announcement announcements
Every Bal Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements
10:58 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
13:34 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending December 31, 2025. This disclosure provides details on share distribution among promoters and public.
17:13 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, as required by SEBI regulations.
12:44 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
BAL PHARMA Ltd filed its quarterly shareholding pattern for Q2 FY2026. The filing details promoter and shareholder holdings without any monetary transaction.
16:19 IST
NSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Limited submitted a compliance certificate for the quarter ended March 31, 2026, confirming the maintenance of a Structured Digital Database (SDD). The company certified that the database is non-tamperable, captures UPSI events, and maintains audit trails. This routine filing indicates full compliance with SEBI Prohibition of Insider Trading Regulations.
12:41 IST
BSE
Other AnnouncementBal Pharma Ltd BALPHARMA
Bal Pharma Other Announcement
Bal Pharma Ltd has submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The company confirmed that share certificates received for dematerialization were processed and depository records updated within the prescribed 15-day limit.